STOCK TITAN
  1. Home
  2. Sec-filings
  3. IVVD
  4. [Form 4] Invivyd, Inc. Insider Trading Activity

Invivyd (IVVD) HR chief sells shares to cover RSU taxes under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Invivyd, Inc. (IVVD) reported insider equity transactions by Chief Human Resources Officer Julie Green. On August 15, 2026, 102,000 restricted stock units converted into an equal number of common shares, representing vesting of an RSU award granted February 15, 2025. To satisfy related tax withholding obligations, she then sold 22,355 shares on August 17, 2026 at a weighted-average price of $0.722 per share and 18,425 shares on August 18, 2026 at a weighted-average price of $0.8429, in non-discretionary sell-to-cover transactions executed under a Rule 10b5-1 trading plan adopted February 20, 2025.

Positive

  • None.

Negative

  • None.
Insider Green Julie
Role Chief Human Resources Officer
Sold 40,780 shs ($32K)
Approx. gross sale proceeds $32K
Type Security Shares Price Value
Sale Common Stock F2, F4 18,425 $0.8429 $16K
Sale Common Stock F2, F3 22,355 $0.722 $16K
Exercise Restricted Stock Units F1, F5 102,000 $0.00 $0.00
Exercise Common Stock F1 102,000 -- --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 168,937 shares (Direct)
Footnotes (5)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
  2. F2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
  3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. F5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Shares sold August 17, 2026 22,355 shares Common stock sale to cover tax withholding
Weighted-average sale price August 17, 2026 $0.722 per share Prices ranged from $0.682 to $0.830
Shares sold August 18, 2026 18,425 shares Common stock sale to cover tax withholding
Weighted-average sale price August 18, 2026 $0.8429 per share Prices ranged from $0.760 to $0.872
RSUs converted to common stock 102,000 shares RSU conversion into common stock on August 15, 2026
RSU vesting period 18 months One-third vests every six months after February 15, 2025 grant
Rule 10b5-1 plan adoption date February 20, 2025 Plan governing sell-to-cover transactions
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
sell-to-cover financial
"shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
Rule 10b5-1 plan financial
"non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

What insider transactions did Invivyd (IVVD) executive Julie Green report on this Form 4?
Julie Green reported vesting and conversion of 102,000 RSUs into common stock on August 15, 2026, followed by sales of 22,355 shares on August 17 and 18,425 shares on August 18, primarily to cover tax withholding obligations.

How many Invivyd (IVVD) shares did Julie Green sell, and at what prices?
Julie Green sold 22,355 shares of Invivyd common stock at a weighted-average price of $0.722 and 18,425 shares at a weighted-average price of $0.8429, with underlying trade prices ranging from $0.682–$0.830 and $0.760–$0.872, respectively.

Why were Invivyd (IVVD) shares sold in Julie Green’s Form 4 filing?
The disclosed sales represent non-discretionary sell-to-cover transactions to satisfy Julie Green’s tax withholding obligations arising from RSU vesting, rather than optional open-market disposals, according to the filing’s footnotes describing the purpose of these transactions.

What RSU vesting schedule did Invivyd (IVVD) report for Julie Green’s award?
The RSU award for Julie Green vests over eighteen months, with one-third of the restricted stock units vesting every six months after the February 15, 2025 grant date, subject to her continuous service with Invivyd as of each vesting date.

Was Julie Green’s Invivyd (IVVD) trading activity under a Rule 10b5-1 plan?
Yes. The filing states the sell-to-cover transactions were made under a Rule 10b5-1 trading plan that Julie Green adopted on February 20, 2025, indicating the sales followed a pre-arranged, non-discretionary trading program.

How many Invivyd (IVVD) RSUs converted to common stock for Julie Green?
A total of 102,000 restricted stock units (RSUs) converted into 102,000 shares of common stock for Julie Green on August 15, 2026, reflecting a scheduled vesting event from an RSU award originally granted on February 15, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Green Julie
(Last)(First)(Middle)
C/O INVIVYD, INC.
205 CHURCH STREET
(Street)
NEW HAVEN CONNECTICUT 06510
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Human Resources Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/15/2026M102,000A(1)209,717D
Common Stock08/17/2026S22,355(2)D$0.722(3)187,362D
Common Stock08/18/2026S18,425(2)D$0.8429(4)168,937D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)08/15/2026M102,000 (5) (5)Common Stock102,000$00D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
/s/ Jill Andersen attorney-in-fact for Julie Green08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR